Abstract
The ferritin level, a protein responsible for iron metabolism and storage, is a sensitive indicator of iron overload in various pathological conditions. In leukemia, ferritin levels increase with disease stages and can predict survival after transplantation. Leukemia-induced dysregulation of the ferroportin-hepcidin regulatory axis results in intracellular iron accumulation, activation of the reactive oxygen species (ROS)-related signaling pathway, and inhibition of hematopoiesis, leading to anemia and increased dependence on red blood cell transfusions, thereby disrupting the physiological cycle. Additionally, ferritin levels rise in other types of cancer, indicating its potential as a target for both diagnosis and treatment. Therefore, understanding the role of ferritin and iron metabolism in leukemia and other diseases is crucial in developing effective treatment strategies to enhance patient outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
